A Randomised Phase 2 Trial of Dexamethasone Versus Prednisolone in Castration-resistant Prostate Cancer
Ramachandran Venkitaraman(University of Suffolk), Chris Parker(Royal Marsden NHS Foundation Trust), David Lorente(Hospital Universitari i Politècnic La Fe), Karen Thomas(Royal Glamorgan Hospital), Robert Huddart(Institute of Cancer Research), Vedang Murthy(Homi Bhabha National Institute), Ruth Ahiabor(Institute of Cancer Research), Johann S. de Bono(Royal Marsden NHS Foundation Trust), Lydia Parker(Institute of Cancer Research), David P. Dearnaley(Royal Marsden NHS Foundation Trust)
Cited by 94
Related Papers
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
|New England Journal of Medicine|2013|3.3k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k